Tectonic Therapeutic, Inc. 4

Chief Scientific Officer Peter McNamara received an employee stock option award for 21,000 shares of Tectonic Therapeutic, Inc. common stock at an exercise price of $29.92 per share.

On September 3, 2026, Chief Scientific Officer Peter McNamara of Tectonic Therapeutic, Inc. was granted a non‑employee stock option to purchase 21,000 shares of common stock at an exercise price of $29.92 per share. This option award is structured to vest over time, with one-eighth of the underlying shares vesting on September 3, 2026 and the remaining shares vesting in 42 equal monthly installments beginning October 3, 2026, contingent on his continued service to the company. The transaction is a compensation-related equity grant rather than an open‑market purchase or sale, and results in derivative ownership of 21,000 option shares, corresponding to 21,000 underlying shares of common stock.

Filing Facts

CIK

1681087

Ticker

TECX

Form

4

Source Type

fda

Accession

0002023255-26-000011

Alert Tier

5